Canzon Israel Ltd (CNZN.TA)
Canzon Israel Ltd operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Tel Aviv, IL. The stock last traded at $143.00, down 5.30% on the session, giving a market capitalisation of $6.5M. Its beta of 1.00 implies it has historically moved less than the broad market.
Canzon Israel Ltd, functioning as a holding entity, primarily focuses on financing the development of residential and commercial properties throughout Israel. Its business scope also encompasses the provision of real estate and logistics services. The firm, which was established in 1999, is headquartered in Tel Aviv-Yafo, Israel. It adopted its current name, Canzon Israel Ltd, in June 2019, having previously been known as User Trend Ltd.